Georgia

No — Georgia allows asynchronous-first care. A licensed Georgia provider can review your intake by secure message and prescribe semaglutide without a scheduled video call, as long as the standard of care is met. Your provider may request a brief video visit or additional information only if your history calls for it.

Start Pallas's online intake — it takes about 5 minutes and covers your health history, goals, and current medications. Because Georgia allows asynchronous-first telehealth, a Georgia-licensed clinician can review your intake by secure message, without a scheduled video call, as long as the standard of care is met — an out-of-state license is not sufficient; every Pallas clinician who treats Georgia patients holds an active Georgia medical license. If a GLP-1 is clinically appropriate, your clinician prescribes it, and a US-licensed pharmacy ships your medication to any Georgia address, usually within 2–3 business days.

The process is the same as for semaglutide — complete Pallas's online intake, and a Georgia-licensed clinician reviews it, typically asynchronously by secure message. If appropriate, your clinician can prescribe either compounded tirzepatide, prepared per-patient by a US-licensed §503A pharmacy based on a documented clinical rationale, or an FDA-approved brand-name option like Zepbound^® or Mounjaro^®, through the same intake. Compounded tirzepatide prescribed by a Georgia-licensed provider and dispensed by a licensed compounding pharmacy is legal when prepared for an individual patient with a documented clinical need — Pallas works only with U.S. state-licensed 503A and 503B compounding pharmacies. These are distinct products with different regulatory status; your clinician will explain which fits you.

Yes — compounded semaglutide is available to eligible Georgia residents through licensed telehealth. It is prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, and a Georgia-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale. Pallas serves Georgia with free shipping. FDA-approved brand-name options like Wegovy^® and Zepbound^® are also available through the same intake.

Several licensed telehealth platforms serve Georgia residents seeking compounded semaglutide. Before choosing one, verify that its clinicians are licensed in Georgia, that it works with US-licensed §503A compounding pharmacies, and that it holds LegitScript Healthcare Merchant Certification — you can check any platform's certification status in LegitScript's public database. Pallas serves Georgia residents and is LegitScript Healthcare Merchant Certified.

Most Georgia patients complete online intake in about five minutes, and a Georgia-licensed clinician typically reviews it within 1–2 business days, since Georgia allows asynchronous-first care with no mandatory video visit. If semaglutide is clinically appropriate, your prescription goes to a US-licensed pharmacy, which ships to any Georgia address in 2–3 business days after filling. An incomplete intake, a missing ID or photo, or a clinician requesting a follow-up video visit can add time — there is no guaranteed timeline, since review depends on your individual history.

Yes — telehealth access through Pallas is the same across Georgia, whether you're in Atlanta, Augusta, Columbus, Savannah, Athens, or a smaller community in South Georgia or along the coastal Golden Isles. A Georgia-licensed clinician reviews every intake the same way regardless of ZIP code, and licensed partner pharmacies ship both compounded medications and FDA-approved brands like Wegovy^® to any Georgia address. Distance from Atlanta does not change your eligibility or your care.

Several telehealth providers prescribe tirzepatide to Georgia residents. Before choosing one, verify that its clinicians hold an active Georgia medical license, that it works with US-licensed §503A compounding pharmacies (or offers FDA-approved Zepbound^®/Mounjaro^® as the brand-name option), and that it carries LegitScript Healthcare Merchant Certification — checkable in LegitScript's public database. Pallas serves Georgia residents and is LegitScript Healthcare Merchant Certified.

Georgia Medicaid covers certain GLP-1s for FDA-approved diabetes indications with prior authorization, and coverage for weight-loss indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service, so Medicaid coverage rules do not affect our pricing.

Most Georgia patients receive their medication within 2–3 business days of the pharmacy filling the prescription. Atlanta, Augusta, Savannah, and other metro ZIP codes typically ship fastest; rural Georgia addresses may take an extra day.

Pallas is a cash-pay telehealth service — there is no insurance to bill. Your Pallas Membership covers your clinician's review, ongoing check-ins, and care-team messaging; the medication is billed separately and ships free to your Georgia address, only when a clinician prescribes it. You see your full price during intake before you pay anything — no surprise renewal markups. The price is the same whether you are in Atlanta, Savannah, or a rural Georgia ZIP code.

In general, GLP-1 medications for weight management are considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher together with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. Eligibility is always decided by a Georgia-licensed clinician after reviewing your full intake, never by an automated quiz — your clinician also reviews your medical history and current medications to confirm a GLP-1 is appropriate and safe for you, and will tell you if it is not.

Brand-name medications — Wegovy^® and Ozempic^® (semaglutide) and Zepbound^® and Mounjaro^® (tirzepatide) — are FDA-approved products from their manufacturers, offered cash-pay. Compounded semaglutide and tirzepatide are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy, when a clinician documents a patient-specific clinical need. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Which option fits you is a clinical decision you make with your Georgia-licensed provider.

Most patients use a once-weekly injection with a very fine needle, but a compounded oral semaglutide tablet is available for people who would rather not inject. Both are prescribed only after a clinician confirms they are appropriate for you, and your provider can help you weigh which form fits your routine and goals.

The most common side effects are gastrointestinal — nausea, constipation, diarrhea, or reflux — and they are usually mildest when the dose is raised slowly, which is why clinicians titrate up gradually. GLP-1s are not right for everyone; they are avoided in people with a personal or family history of medullary thyroid carcinoma or MEN2, and during pregnancy. Your Pallas clinician screens for these before prescribing and stays available to help you manage any side effects.

You complete a detailed online intake in under five minutes, sharing your health history, goals, and current medications. A clinician licensed by the Georgia Composite Medical Board reviews it asynchronously in most cases — no live video required — and may follow up by secure message or request labs if your history calls for it. If a GLP-1 is appropriate, your prescription goes to a licensed pharmacy that ships to any Georgia address, usually within a few business days.

Yes — your plan renews on a regular cadence so your medication arrives before you run out. Pallas care is ongoing, not a one-time script — your clinician schedules check-ins to monitor your response, adjust your dose, and manage side effects, and you can message your care team, change your plan, or cancel anytime from your patient portal — no phone calls or retention hoops.

Yes. Georgia nurse practitioners prescribe under a nurse protocol agreement — a written agreement with a delegating Georgia physician that is filed with the Georgia Composite Medical Board under O.C.G.A. § 43-34-25. Semaglutide and tirzepatide are not controlled substances, and a Georgia-licensed clinician can prescribe them through telehealth. Every Pallas clinician who treats Georgia patients holds an active Georgia license.

Compounded semaglutide injection through Pallas is $139 first month, then $597 every 12 weeks ($199/mo average), charged once a clinician prescribes. Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Georgia address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.

Compounded tirzepatide injection through Pallas is $179 first month, then $897 every 12 weeks ($299/mo average), charged once a clinician prescribes. Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Georgia address, only if a clinician prescribes it, and you are refunded in full if a clinician decides treatment isn't right for you.

Yes. FDA-approved Wegovy^® and Zepbound^® for chronic weight management — plus Ozempic^® and Mounjaro^® for type 2 diabetes — are available to Georgia patients cash-pay from $1069/mo; insurance is not billed. Whether a brand-name or compounded medication is appropriate for you is determined by a clinician licensed in Georgia during intake.

Coverage of GLP-1 medications for weight loss through Medicaid is limited. Georgia Medicaid covers GLP-1s like semaglutide for type 2 diabetes with prior authorization. Coverage for weight-loss indications is limited and step therapy applies. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service — we do not bill Medicaid or private insurance. Pricing is flat and disclosed up front; the cost questions on this page carry current plan terms.

You have two cash-pay paths in Georgia, and neither requires insurance. One: stay on FDA-approved Wegovy^® or Zepbound^® at flat cash-pay pricing from $1069/mo. Two: if a clinician licensed in Georgia determines it is clinically appropriate for you, a compounded semaglutide plan ($139 first month, then $597 every 12 weeks ($199/mo average), charged once a clinician prescribes. Cancel anytime.) or compounded tirzepatide plan ($179 first month, then $897 every 12 weeks ($299/mo average), charged once a clinician prescribes. Cancel anytime.), prepared per-patient by a US-licensed pharmacy under FDCA §503A. There is no gap in care: start the online intake, tell your clinician what you take now and your current dose, and they factor that history into your treatment plan and starting dose. Our guide to switching GLP-1 telehealth providers on the Pallas blog covers records, timing, and what to expect.

That is a decision you make with your clinician. Semaglutide activates the GLP-1 receptor; tirzepatide activates both the GLP-1 and GIP receptors. In the SURMOUNT-5 head-to-head trial of the FDA-approved products, Zepbound^® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy^® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks. Wegovy^®'s maximum dose is now 7.2 mg weekly, which was not studied in SURMOUNT-5; in the separate STEP UP trial it reached 18.7% average weight loss over 72 weeks. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary. Semaglutide plans cost less and semaglutide has the longer post-market record; a clinician licensed in Georgia weighs your history, goals, and budget to recommend a starting point.